Obesity drugmaker BioAge targets $158 million in IPO ...Middle East

company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday.

Hence then, the article about obesity drugmaker bioage targets 158 million in ipo was published today ( Thursday 19/09/2024 - 01:12 AM ) and is available on Fortune ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Obesity drugmaker BioAge targets $158 million in IPO )

Also on site :

• One Night in Mhoon Valley
• Hegseth says US remains prepared to restart fighting, as Trump weighs Iran deal. Catch up
• Live Nation Acquires Majority Stake in Argentine Promoter Dale Play Live